วันเสาร์ที่ 2 กรกฎาคม พ.ศ. 2554

The most recent in pathology and medicine of Stomach Cancer

The stomach is a sac-like organ located in the upper abdomen between the esophagus and small intestine. It is part of the digestive system, functioning in the storehouse and digestion of food straight through the secretion of gastric juices. After leaving the stomach, partly-digested food passes into the small intestine and then into the large intestine.

The improvement of stomach cancer, also referred to as gastric cancer, usually occurs as a succeed of continuing inflammation. This can be due to both external and internal risk factors. A risk factor is whatever that increases your risk of getting a disease. Risk factors for the improvement of gastric cancer contain the following:

Gastric Cancer

• Having any of the following curative conditions:
- Helicobacter pylori (H. Pylori) infection of the stomach.
- continuing gastritis (inflammation of the stomach).
- Pernicious anemia.
- Intestinal metaplasia (a health in which the normal stomach lining is substituted with the cells that line the intestines).
- Familial adenomatous polyposis (Fap) or gastric polyps.
• Eating a diet high in salted, smoked foods and low in fruits and vegetables.
• Eating foods that have not been prepared or stored properly.
• Being over the age of 55 or male.
• Smoking cigarettes.
• Having a mother, father, sister, or brother who has had stomach cancer.

The most recent in pathology and medicine of Stomach Cancer

According to the National Cancer fabricate (Nci), approximately 760,000 cases of stomach cancer are diagnosed worldwide and more than 24,000 cases are diagnosed in the United States each year. Incidence is highest in Japan, South America, Eastern Europe, and parts of the Middle East. Worldwide, stomach cancer is the second prominent cause of cancer-related deaths. The full, diagnosis of stomach cancer is poor because detection rarely occurs at the preclinical stage.

Diagnosis of stomach cancer involves taking a detailed curative history and performing a corporal examination. Because of the size of the stomach, early symptoms are often non-specific and corporal findings are not gift until the advanced stages of disease. Symptoms in the early stages of gastric cancer contain indigestion, stomach discomfort, a bloated feeling after eating, mild nausea, loss of appetite, or heartburn. In more advanced stages of gastric cancer patients may gift with more intense stomach pain, vomiting, mystery swallowing, weight loss for no known reason, blood in the stool, or a palpable mass on corporal exam.

Upper Gastrointestinal Endoscopy (Egd) is the gold acceptable policy for the detection and diagnosis of gastric cancer. In this policy an endoscope (a thin, lighted tube containing a camera) is passed straight through the mouth and down the throat examining the inside of the esophagus, stomach, and duodenum (first part of the small intestine) to check for abnormal areas. Any unusual masses, protrusions, or ulcerations can be biopsied and sent for pathological diagnosis to rule if cancer cells are present.

Once the diagnosis of gastric cancer has been made, the progression of the extent of disease needs to be considered prior to any interventional treatment. This is done straight through a process called Staging. Once doctors have adequately staged the cancer and know the extent to which it has spread to other parts of the body, they can rule on the best policy of treatment. Ct Scans and Pet Scans have been used for staging to detect the spread of disease to distant parts of the body. Recently, Endoscopic Ultrasound (Eus) has been used in assessing depth of tumor invasion, involvement of regional lymph nodes, or invasion of adjacent organs. Endoscopic Ultrasound allows for a more exact preoperative appraisal of the tumor stage and permits the identification of the subset of patients who are candidates for preoperative chemoradiation therapy.

Surgery for Gastric Cancer
The extent of surgery for the medicine of stomach cancer depends on the extent of the disease. Endoscopic mucosal resection may be used to treat early stomach cancer (tumors smaller than 3 cm that have not invaded the innermost layer of the stomach lining called the submucosa). This policy involves removing only the tumor and surrounding tissue.

Gastrectomy is the most common medicine for stomach cancer. In this surgery, the entire stomach (total gastrectomy) or part of the stomach (partial or sub-total gastrectomy) is removed. Parts of colse to tissues or organs (e.g., the spleen) may also be removed if complicated with tumor. Surrounding lymph nodes are also removed.

Following total gastrectomy, the esophagus is attached directly to the small intestine. When a partial or sub-total gastrectomy is done, the remaining stomach is attached to the small intestine. The association between these organs is called an anastomosis.

Like any major surgery patients may perceive postsurgical pain, weakness, fatigue, and loss of appetite following surgery for gastric cancer. Saving from the policy varies depending on the patient's age and full, health, the type of surgery, and the stage of the disease.

Removal of a large part or all of the stomach usually requires permanent alterations in diet. Patients often must eat more frequently, eat smaller meals, sacrifice their sugar intake, and increase their intake of fat and protein. If a small section is removed, patients may be able to moderately return to former eating habits.

Radiation therapy
Radiation therapy uses high-powered beams of power to kill cancer cells. The power beams come from a machine that moves colse to you as you lie on a table. Radiation therapy can be used before surgery (neoadjuvant radiation) to shrink a stomach tumor so it's more indeed removed. Radiation therapy can also be used after surgery (adjuvant radiation) to kill any cancer cells that might remain colse to your stomach to preclude local recurrence. Radiation is often combined with chemotherapy. In cases of advanced cancer, radiation therapy may be used to relax side effects caused by a large tumor.

Chemotherapy
Chemotherapy is a drug medicine that uses chemicals to kill cancer cells. Chemotherapy drugs tour throughout your body, killing cancer cells that may have spread beyond the stomach. Chemotherapy can be given before surgery (neoadjuvant chemotherapy) to help shrink a tumor so it can be more indeed removed. Chemotherapy is also used after surgery (adjuvant chemotherapy) to kill any cancer cells that might remain in the body. Chemotherapy is often combined with radiation therapy. Chemotherapy may be used alone in habitancy with advanced stomach cancer to help relax signs and symptoms.

Recent studies have shown that the blend of preoperative radiation and chemotherapy in patients with locally advanced stomach cancer leads to an increase in the likelihood of surgical resection, and an improvement in disease free and full, survival. The addition of radiation and chemotherapy postoperatively has also been shown to decrease tumor recurrence and indeed sway sick person survival.

Overall diagnosis depends on the stage of the disease. Stomach cancer metastasizes to distant parts of the body in as many as 80% of cases, resulting in a very poor prognosis. In Japan, where stomach cancer is often diagnosed early, the 5-year survival rate is about 50%. In the United States and most of the Western world, the 5-year survival rate ranges from 5-15%.

The most recent in pathology and medicine of Stomach Cancer

ไม่มีความคิดเห็น:

แสดงความคิดเห็น